![Brian Shew](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Brian Shew
Direttore Tecnico/Scientifico/R&S presso IOVANCE BIOTHERAPEUTICS, INC.
Provenienza dei contatti di primo grado di Brian Shew
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Jazz Pharmaceuticals, Inc.
![]() Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA.
24
| Subsidiary | Pharmaceuticals: Major | 24 |
Public Company | Biotechnology | 19 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Brian Shew tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
JAZZ PHARMACEUTICALS PLC | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Director/Board Member Director/Board Member Director of Finance/CFO President Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member Chief Operating Officer President Chief Tech/Sci/R&D Officer General Counsel Director/Board Member Human Resources Officer | |
MERCK & CO., INC. | Pharmaceuticals: Major | Sales & Marketing Human Resources Officer Corporate Officer/Principal Director/Board Member | |
HALOZYME THERAPEUTICS, INC. | Biotechnology | Chairman Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
AMGEN INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Sales & Marketing | |
ALZA CORPORATION | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
Yale University | College/University | Undergraduate Degree Doctorate Degree | |
GLOBAL BLOOD THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Human Resources Officer | |
Harvard Business School | College/University | Corporate Officer/Principal Masters Business Admin | |
BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Director/Board Member Director/Board Member | |
Epirium Bio, Inc.
![]() Epirium Bio, Inc. Pharmaceuticals: MajorHealth Technology Epirium Bio, Inc. develops therapeutics for orphan and rare diseases characterized by impairment of the skeletal muscle, cardiac and neuronal systems. The company was founded in 2008 by Alan Stewart Maisel, Sundeep Dugar, and Francisco Villarreal and is headquartered in Los Altos Hills, CA. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
The Pennsylvania State University | College/University | Doctorate Degree Undergraduate Degree | |
Actelion Pharmaceuticals US, Inc.
![]() Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Actelion Pharmaceuticals US, Inc. is based in Titusville, NJ. Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a company that manufactures, distributes, and markets drugs. The CEO of the company is Samuele Butera. | Pharmaceuticals: Major | Corporate Officer/Principal Compliance Officer | |
George Washington University | College/University | Graduate Degree Graduate Degree | |
PFIZER, INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
MEDIVATION INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
State University of New York at Binghamton | College/University | Undergraduate Degree Undergraduate Degree | |
GOSSAMER BIO, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Kartos Therapeutics, Inc.
![]() Kartos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kartos Therapeutics, Inc. is a clinical stage biopharmaceutical company based in Redwood City, CA. Kartos Therapeutics, Inc. is focused on developing a potential MDM2 inhibitor for the treatment of various TP53 wild-type hematological malignancies and solid tumors. The company was founded by Wayne P. Rothbaum and Iain David Dukes, and the CEO is Jesse Seton McGreivy. | Pharmaceuticals: Major | Founder Founder | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Sales & Marketing Chief Tech/Sci/R&D Officer | |
TARSUS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Sales & Marketing | |
ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
CORCEPT THERAPEUTICS INCORPORATED | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
The University of Chicago | College/University | Masters Business Admin Graduate Degree | |
University of California, Los Angeles | College/University | Undergraduate Degree Undergraduate Degree | |
OrbiMed Advisors Private Equity
![]() OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor | |
NeRRe Therapeutics Ltd.
![]() NeRRe Therapeutics Ltd. Medical DistributorsDistribution Services NeRRe Therapeutics Ltd. provides clinical and pre clinical drugs for treatment of neuronal hypersensitivity. It develops neurokinin receptor antagonists acquired from GlaxoSmithKline. The company was founded by Emiliangelo Ratti and Mike Trower in 2012 and is headquartered in Stevenage, the United Kingdom. | Medical Distributors | Director/Board Member | |
ReViral Ltd.
![]() ReViral Ltd. BiotechnologyHealth Technology ReViral Ltd. specializes in the areas of virology and antiviral therapies. It offers drugs to treat respiratory synctial virus infection. The company was founded by Neil Matthews and Stuart Cockerill in 2011 and is headquartered in Stevenage, the United Kingdom. | Biotechnology | Director/Board Member | |
KaNDy Therapeutics Ltd.
![]() KaNDy Therapeutics Ltd. BiotechnologyHealth Technology KaNDy Therapeutics Ltd. engages in the provision of a treatment of chronic debilitating female sex-hormone related conditions. Its product is NT-814 a non-hormonal therapy to treat moderate to severe post-menopausal vasomotor symptoms. The company was founded by Dr. Mike Trower and Mary Kerr in 2017 and is headquartered in Stevenage, the United Kingdom. | Biotechnology | Chairman | |
Themis Bioscience GmbH
![]() Themis Bioscience GmbH Pharmaceuticals: MajorHealth Technology Themis Bioscience GmbH operates as a biotechnology company, which engages in the development of prophylactic vaccinations from preclinical to early clinical phase. The firm focuses on the prevention of tropical infectious diseases. Its proprietary Themaxyn technology platform, in-licensed from Paris-based Institute Pasteur, forms the basis of all of the company's vaccine candidates. The company was founded by Erich Tauber in 2009 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Director/Board Member | |
IKENA ONCOLOGY, INC. | Biotechnology | Director/Board Member | |
Angiex, Inc.
![]() Angiex, Inc. Miscellaneous Commercial ServicesCommercial Services Angiex, Inc. operates as a biotechnology company, which engages in the development of an antibody-drug conjugate therapy for cancer. It focuses on TM4SF1, a membrane glycoprotein of tetraspanin topology that was originally discovered as a protein expressed on many human epithelial tumor cells. The company was founded by Paul Jaminet, Harold Dvorak, and Shou-Ching Jaminet in 2015 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member | |
Telios Pharmaceuticals, Inc.
![]() Telios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Integra LifeSciences Holdings Corp., Telios Pharmaceuticals, Inc. is a pharmaceutical company focused on research. The company is based in San Diego, CA. The company was founded by Iain David Dukes, Erkki Ruoslahti. Telios Pharmaceuticals was acquired by Integra LifeSciences Holdings Corp. on August 17, 1995 for $35 million. | Pharmaceuticals: Major | Founder | |
NeRRe Therapeutics Holdings Ltd.
![]() NeRRe Therapeutics Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services NeRRe Therapeutics Holdings Ltd. is a British biotechnology company founded in 2017. The private company is based in Stevenage, UK. The company is engaged in research and development of biotechnology. | Miscellaneous Commercial Services | Director/Board Member | |
THESEUS PHARMACEUTICALS, INC. | Biotechnology | Chief Executive Officer | |
Viriom, Inc.
![]() Viriom, Inc. Miscellaneous Commercial ServicesCommercial Services Viriom, Inc. is a biotechnology company based in San Diego, CA. The company focuses on developing innovative therapies for infectious diseases, including HIV and COVID-19. Viriom's mission is to improve the lives of patients by providing effective and accessible treatments. Iain David Dukes has been the CEO of the company since 2019, leading the team in their efforts to advance the development of their pipeline and bring new therapies to market. | Miscellaneous Commercial Services | Chief Executive Officer | |
ENYO Pharma SA
![]() ENYO Pharma SA BiotechnologyHealth Technology ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France. | Biotechnology | Director/Board Member | |
TRAWS PHARMA, INC. | Biotechnology | Chairman | |
University of Bath | College/University | Undergraduate Degree | |
Scios, Inc.
![]() Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Pharmaceuticals: Major | Sales & Marketing | |
Texas A&M University | College/University | Undergraduate Degree | |
US Military Academy | College/University | Undergraduate Degree | |
The United States Army (District of Columbia) | Sovereign | Corporate Officer/Principal | |
GILEAD SCIENCES, INC. | Biotechnology | Sales & Marketing | |
BIOGEN INC. | Pharmaceuticals: Major | Sales & Marketing | |
Nodality, Inc.
![]() Nodality, Inc. BiotechnologyHealth Technology Nodality, Inc. develops bioinformatics tools to enhance drug development process. Its technology profiles signaling networks in single cells by multiparametric phospho-flow cytometry. The company was founded by Michael C. Needels, Omar D. Perez, Garry P. Nolan and Rodney Weldon Turner in 2003 and is headquartered in San Francisco, CA. | Biotechnology | Sales & Marketing |
Statistiche
Distribuzione geografica
Stati Uniti | 42 |
Regno Unito | 6 |
Irlanda | 3 |
Austria | 2 |
Francia | 2 |
Settori
Health Technology | 35 |
Consumer Services | 11 |
Commercial Services | 4 |
Finance | 2 |
Distribution Services | 2 |
Posizioni
Director/Board Member | 225 |
Corporate Officer/Principal | 94 |
Independent Dir/Board Member | 93 |
Chairman | 48 |
Undergraduate Degree | 36 |
Contatti più connessi
Insiders | |
---|---|
Merrill McPeak | 38 |
Iain Dukes | 32 |
Elmar Schnee | 31 |
Karen Wilson | 31 |
Kathryn Falberg | 30 |
Norbert Riedel | 29 |
Paul Berns | 28 |
Michael Weiser | 26 |
Wendy Dixon | 25 |
Wendy Yarno | 19 |
Athena Countouriotis | 17 |
Heather McSharry | 15 |
Elena Viboch | 14 |
Renée Galá | 13 |
Russell Cox | 13 |
- Borsa valori
- Insiders
- Brian Shew
- Connessioni Società